Cancer BiologybioRxivPreprint
A breast cancer patient-derived xenograft and organoid platform for drug discovery and precision oncology
K. P. Guillen, M. Fujita, A. J. Butterfield…·A. L. Welm
The paper develops patient-derived xenografts and organoids for breast cancer to enable drug screening and precision oncology, showing efficacy of an FDA-approved drug in a clinical case.
DOI 10.1101/2021.02.28.433268